Literature DB >> 2140390

Purification of MEA, a mast cell growth-enhancing activity, to apparent homogeneity and its partial amino acid sequencing.

J Moeller1, L Hültner, E Schmitt, M Breuer, P Dörmer.   

Abstract

A novel growth factor for bone marrow derived murine mucosal type mast cells has been isolated from the conditioned medium of the Mlsa-reactive mouse Th cell line MLS-4.2. In proliferation assays this growth factor synergizes, like IL-4, with IL-3 on established mast cell lines and was therefore termed MEA: mast cell growth enhancing activity. MEA was characterized as a glycoprotein with a Mr range between 37,000 and 43,000. Apparent homogeneity was obtained by using a four-step purification scheme including cation exchange chromatography, Procion red affinity chromatography, IEF, and gel filtration. Inasmuch as MEA was N-terminally blocked during automated Edman-degradation, peptide fragments after digestion with trypsin were used for partial amino acid sequence determination. All evaluable MEA peptide fragments showed complete sequence homology to a recently purified and cloned novel T cell growth factor (P40/TCGF III), the mouse homologue of human IL-9.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140390

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Dog mastocytoma cells produce transforming growth factor beta 1.

Authors:  D W Pennington; A R Lopez; P S Thomas; C Peck; W M Gold
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 2.  The dichotomous function of interleukin-9 in cancer diseases.

Authors:  K Gerlach; B Weigmann
Journal:  J Mol Med (Berl)       Date:  2019-08-08       Impact factor: 4.599

Review 3.  Th9 cells in inflammatory bowel diseases.

Authors:  Benno Weigmann; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2016-11-11       Impact factor: 9.623

4.  Kinetics of interleukin-6 production after experimental infection of mice with Schistosoma mansoni.

Authors:  R M Khalil; L Hültner; R Mailhammer; A Luz; J Moeller; A A Mohamed; S Omran; P Dörmer
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

5.  Schistosoma mansoni infection in mice augments the capacity for interleukin 3 (IL-3) and IL-9 production and concurrently enlarges progenitor pools for mast cells and granulocytes-macrophages.

Authors:  R M Khalil; A Luz; R Mailhammer; J Moeller; A A Mohamed; S Omran; P Dörmer; L Hültner
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Expression cloning of the murine and human interleukin 9 receptor cDNAs.

Authors:  J C Renauld; C Druez; A Kermouni; F Houssiau; C Uyttenhove; E Van Roost; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

7.  Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes.

Authors:  C Petit-Frere; B Dugas; P Braquet; J M Mencia-Huerta
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

8.  Effect of Th9/IL-9 on the growth of gastric cancer in nude mice.

Authors:  Li Cai; Yue Zhang; Yifei Zhang; Hongbing Chen; Jinchen Hu
Journal:  Onco Targets Ther       Date:  2019-03-26       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.